Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation

SIMPLE SUMMARY: Recently, antiplatelet agents have been shown to have anticancer effects, especially for hepatocellular carcinoma (HCC) but have never been studied in liver transplantation (LT) recipients. We investigated 468 LT patients to ensure that antiplatelet drugs (aspirin or clopidogrel) cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Mun Chae, Min, Eun-Ki, Lee, Jae Geun, Joo, Dong Jin, Kim, Myoung Soo, Kim, Deok-Gie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654602/
https://www.ncbi.nlm.nih.gov/pubmed/36358749
http://dx.doi.org/10.3390/cancers14215329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654602/
https://www.ncbi.nlm.nih.gov/pubmed/36358749
http://dx.doi.org/10.3390/cancers14215329

Ejemplares similares